Manchester Mental Health & Social Trust - Early Interventions Training
Unit 3 - Interventions in First Episode Psychosis
Session 3.2 – Medication
Trainers Guide
Putting the Session into Context:
This session is designed both for those who have little experience of mental health problems and for those with a more advanced knowledge, which they need to refresh and develop.
The level at which the trainers pitch the session will be dependant on their quick assessment of the group’s working knowledge of issues of medication and its management.
Teaching materials required:
A flipchart /pens
Large sheets of paper for group work, pens and adhesive putty.
Handouts of overheads
Group work exercises
Lap top and projector or acetates and OHP
Reflective workbook
Evaluation Sheets
Training Outcomes:
After completion of this unit participants will be expected to:
Have gained an understanding of why antipsychotic medication is prescribed, how it is prescribed and dispensed, and how it is administered.
To be aware of the issues of medication concordance.
To be aware of the use of medication specifically in 1st episode psychosis.
To be familiar with the common side effects of antipsychotic medication and with the severe adverse effects that they can cause – heart problems, diabetes, tardive diskynesia etc.
To have worked in groups to explore current knowledge levels about different types of medication and which mental health problems they are used for.
To have worked in groups to have explored issues of concordance with medication from personal experience and how this can be linked to issues of compliance in people with 1st onset psychosis.
For participants to be aware of the received understanding of neurochemistry, neurotransmitters and medication.
References
.
Bentall RP and Morrison AP (2002) More harm than good: The case against using antipsychotic drugs to prevent severe mental illness. Journal of Mental Health II, 351 – 365.
Johnstone EC, Crow TJ, Johnson A and MacMillan J (1986) The Northwicke Park study for first episode schizophrenia, I: Presentations of the illness and problems relating to admission. British Journal of Psychiatry 148, 115 – 120.
Lean ME and Pajonk FG (2003) Patients on atypical antipsychotic drugs: another high risk group for type 2 diabetes. Diabetes Care 26 (5), 1597 - 1605.
Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH and Szymanski SR (1992) Duration of psychosis and outcome in first episode schizophrenia. American Journal of Psychiatry, 149, 1183 – 1188.
McGorry PD and Singh BS (1995) Schizophrenia: Risk and possibility of prevention. In Raphael and Burrows (eds) Handbook of studies on preventive psychiatry. Elsivier Science.
McGorry PD, Yung AR, Phillips LJ et al (2002) Randomised controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with sub-threshold symptoms. Archives of General Psychiatry, 59 (10) 921 – 928.
Morrison AP, French P, Walford L et al (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk. British Journal of Psychiatry 185, 291 297.
NICE (2002a) Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. Technology Appraisal No. 43. National Institute for Clinical Excellence.
NICE (2002b) Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical guideline No 1. National Institute of Clinical Excellence.
Sernyak MJ, Leslie DL, Alarcon RD et al (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159 (4), 561 - 566.
Further Reading :
Geddes J, Freemantle N, Harrison P and Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. British Medical Journal 321 (7273), 1371 - 1376.
Harris N (2002) Neuroleptic medication. In N Harris, S Williams and T Bradshaw (eds) Psychosocial interventions for psychosis. London, Palgrave MacMillan.
Warner R (1994) Recovery from schizophrenia. London Routledge.
.
1